C5aR1 antagonist (Vanqua Bio)

N/A

Report date: 2025/06/11 10:32:08
NME

Base Information

Drug NameC5aR1 antagonist (Vanqua Bio)
Drug Alias NameComplement receptor C5aR1
ClassificationSmall molecules
Mechanisms of ActionComplement receptor type 1 antagonists
TargetsComplement receptor type 1
Therapy Area/IndicationsInflammationAlzheimer DiseaseMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVanqua Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesVanqua Bio Inc
Inactive CompaniesN/A
Active IndicationsInflammationAlzheimer DiseaseMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A